about
Genetic disorders coupled to ROS deficiencyRedox regulation of T-cell function: from molecular mechanisms to significance in human health and diseaseLong-Term Effects of (-)-Epigallocatechin Gallate (EGCG) on Pristane-Induced Arthritis (PIA) in Female Dark Agouti RatsNitric oxide-driven hypoxia initiates synovial angiogenesis, hyperplasia and inflammatory lesions in miceHarmful waste products as novel immune modulators for treating inflammatory arthritis?Arthritis suppression by NADPH activation operates through an interferon-beta pathwayA transient peak of infections during onset of rheumatoid arthritis: a 10-year prospective cohort studyTargeting NOX enzymes in the central nervous system: therapeutic opportunities.Phagocyte NADPH oxidase, chronic granulomatous disease and mycobacterial infections.The connection of monocytes and reactive oxygen species in pain.Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivoToxins Targeting the Kv1.3 Channel: Potential Immunomodulators for Autoimmune DiseasesDevelopment of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseasesToll-like receptor signaling in primary immune deficiencies.Loss of NOX-Derived Superoxide Exacerbates Diabetogenic CD4 T-Cell Effector Responses in Type 1 DiabetesReactive oxygen species produced by the NADPH oxidase 2 complex in monocytes protect mice from bacterial infections.Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.Antiarthritic effect of aqueous and ethanolic leaf extracts of Pistia stratiotes in adjuvant-induced arthritis in Sprague-Dawley rats.Is there a feudal hierarchy amongst regulatory immune cells? More than just Tregs.Pharmacological control of neutrophil-mediated inflammation: strategies targeting calcium handling by activated polymorphonuclear leukocytesMicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats.Plant volatiles: production, function and pharmacology.Immunoregulation through membrane proteins modified by reducing conditions induced by immune reactions.Ncf1 polymorphism reveals oxidative regulation of autoimmune chronic inflammation.Reactive oxygen homeostasis - the balance for preventing autoimmunity.Susceptibility to chronic inflammation: an update.Cell death and cytokine production induced by autoimmunogenic hydrocarbon oils.Inhibition of the lymphocyte metabolic switch by the oxidative burst of human neutrophils.Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species.The effects of Euphorbia hirta on the ultrastructure of the murine liver, kidney and aortaInfluence of hydrocarbon oil structure on adjuvanticity and autoimmunity.Chemical Tools for Targeted Amplification of Reactive Oxygen Species in NeutrophilsOverexpression of Toll-Like Receptor 3 in Spleen is Associated with Experimental Arthritis in Rats
P2860
Q26799545-54163457-34D7-4F2C-9220-61278265CDB7Q26824042-39D8B0F9-D337-4BCD-89D4-23EF2C6C748BQ27316058-7DA53570-BE7C-4A95-9AFE-2A2B8A364D25Q28482073-E368C7A3-522F-4AD4-B35A-D33844955F19Q33257260-6D81217E-21DC-4BF5-8956-A48243B48A9DQ33284147-B243E791-971C-405B-92DF-C3311BFBD1C4Q34144942-DE77E341-9EE1-487F-83F1-53D341859786Q34285497-326E65A2-FE23-42C2-A7BE-58977F3D01C4Q34423996-B7543E97-1134-4D8D-95FF-AC5185EA2F4CQ34713303-ACB04945-6015-4022-B21E-B0668512F66FQ35238066-2AFFF512-C0E2-472A-9B39-AD7F8E231B6EQ35662935-9B5FE30A-4A27-4D41-A0C2-30B7B3535D8AQ36097325-F7908E14-59F3-4525-844F-5AA4365DAC2BQ36238886-5F588AFC-F31E-463D-9135-E6425B2F7180Q36311560-D2475DDC-7CC8-4555-81CB-328D557D78DDQ36593591-C6D3FAE3-4720-4340-AE9A-1678372F88ACQ36598097-A0D4EACB-2648-45B2-AF7C-6228AD409E9CQ36891081-32906FE2-5B82-4271-8976-B6DCE74E0206Q37350865-2F0D4640-FB23-4505-B9D2-9D70D6008A9EQ37385606-07C55946-0FE9-4603-8222-8BB351D79D8BQ37689727-F369A533-01DA-43DF-A28B-8886D95DE868Q37889127-1DE155F8-2425-47A3-B8E5-A38078D15E5DQ38066808-272AE119-B3D0-4960-95EC-590DBBE23D28Q38673434-C41C386C-002D-4C65-8097-1D3F10519F4CQ38851117-5D5D2F7E-9897-4898-8E1E-29BA18448895Q39107170-7FAE0562-62E9-4EF8-AC39-A610A5BF1ECDQ39292218-88E9F9BA-E286-4566-A65B-1167B79A0E3AQ41251598-F23A084E-DC23-440E-B2D0-CA42D0336521Q41377170-F20CA6ED-160C-48C1-9228-EDFC33A01E5AQ42090375-473F8F39-94D0-46A5-ADF0-9C67EE437DD6Q47151298-17398A8B-C204-4DD9-B524-9497AD82D9BEQ58785705-AFA86D28-0B90-4B19-9371-E75BD38D3B2BQ58809183-4A71DCF3-AC29-4FBA-AB5F-E4E31B06F3AF
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
A new arthritis therapy with oxidative burst inducers
@ast
A new arthritis therapy with oxidative burst inducers
@en
A new arthritis therapy with oxidative burst inducers
@nl
type
label
A new arthritis therapy with oxidative burst inducers
@ast
A new arthritis therapy with oxidative burst inducers
@en
A new arthritis therapy with oxidative burst inducers
@nl
prefLabel
A new arthritis therapy with oxidative burst inducers
@ast
A new arthritis therapy with oxidative burst inducers
@en
A new arthritis therapy with oxidative burst inducers
@nl
P2093
P2860
P3181
P1433
P1476
A new arthritis therapy with oxidative burst inducers
@en
P2093
Jens Holmberg
Kyra A Gelderman
Malin Hultqvist
Peter Olofsson
Rikard Holmdahl
P2860
P3181
P356
10.1371/JOURNAL.PMED.0030348
P407
P577
2006-09-01T00:00:00Z